Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

SQZ Biotechnologies Company SQZ

Full chart Compare
Set alert

Price alert · SQZ

All alert types
0.44 +0.44

Day range unavailable

52-week range unavailable

Financial health

Altman Z-Score

-22.91 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.3×
FY 2018: -9.9×FY 2019: -7.4×FY 2020: -3.1×FY 2021: -3.6×FY 2022: -0.3×
FY 2018 5y median -3.6× FY 2022
P/S 1.0×
FY 2018: 15.1×FY 2019: 12.3×FY 2020: 7.5×FY 2021: 9.1×FY 2022: 1.0×
FY 2018 5y median 9.1× FY 2022
P/B 0.4×
FY 2018: -4.4×FY 2019: -3.2×FY 2020: 1.2×FY 2021: 2.0×FY 2022: 0.4×
FY 2018 5y median 0.4× FY 2022
P/FCF -0.3×
FY 2018: 3.2×FY 2019: -6.7×FY 2020: -3.5×FY 2021: -3.0×FY 2022: -0.3×
FY 2018 5y median -3.0× FY 2022
EV/EBITDA 0.3×
FY 2018: -7.2×FY 2019: -8.0×FY 2020: -0.8×FY 2021: -3.0×FY 2022: 0.3×
FY 2018 5y median -3.0× FY 2022
EV/Sales -0.7×
FY 2018: 10.4×FY 2019: 12.4×FY 2020: 1.6×FY 2021: 6.4×FY 2022: -0.7×
FY 2018 5y median 6.4× FY 2022
FCF Yield -394.3%
FY 2018: 31.6%FY 2019: -15.0%FY 2020: -28.3%FY 2021: -33.6%FY 2022: -394.3%
FY 2018 5y median -28.3% FY 2022

Profitability

Gross Margin 100.0%
FY 2018: 100.0%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%
FY 2018 5y median 100.0% FY 2022
Operating Margin -383.7%
FY 2018: -161.1%FY 2019: -177.4%FY 2020: -243.2%FY 2021: -253.8%FY 2022: -383.7%
FY 2018 5y median -243.2% FY 2022
Net Margin -372.1%
FY 2018: -151.9%FY 2019: -166.7%FY 2020: -238.0%FY 2021: -253.5%FY 2022: -372.1%
FY 2018 5y median -238.0% FY 2022
ROE -136.9%
FY 2018: 44.2%FY 2019: 43.8%FY 2020: -39.3%FY 2021: -55.4%FY 2022: -136.9%
FY 2018 5y median -39.3% FY 2022
ROIC -93.9%
FY 2018: -21.7%FY 2019: -27.7%FY 2020: -26.0%FY 2021: -33.9%FY 2022: -93.9%
FY 2018 5y median -27.7% FY 2022
ROA -78.3%
FY 2018: -16.7%FY 2019: -21.1%FY 2020: -21.6%FY 2021: -30.4%FY 2022: -78.3%
FY 2018 5y median -21.6% FY 2022

Growth (YoY)

Revenue -22.4%
FY 2018: 0.0%FY 2019: 52.5%FY 2020: 8.7%FY 2021: 29.1%FY 2022: -22.4%
FY 2018 FY 2022
Operating Income -17.3%
FY 2018: 0.0%FY 2019: -67.9%FY 2020: -49.0%FY 2021: -34.7%FY 2022: -17.3%
FY 2018 FY 2022
EPS (diluted) -9.2%
FY 2018: 0.0%FY 2019: -34.3%FY 2020: -413.9%FY 2021: 73.1%FY 2022: -9.2%
FY 2018 FY 2022
Free Cash Flow -1.6%
FY 2018: 0.0%FY 2019: -159.1%FY 2020: -24.3%FY 2021: -86.7%FY 2022: -1.6%
FY 2018 FY 2022

Financial Health

Current Ratio 3.1×
FY 2018: 5.1×FY 2019: 2.7×FY 2020: 3.9×FY 2021: 4.5×FY 2022: 3.1×
FY 2018 5y median 3.9× FY 2022
Quick Ratio 3.1×
FY 2018: 5.1×FY 2019: 2.7×FY 2020: 3.9×FY 2021: 4.5×FY 2022: 3.1×
FY 2018 5y median 3.9× FY 2022
Debt / Equity 0.5×
FY 2018: 0.0×FY 2019: -0.6×FY 2020: 0.4×FY 2021: 0.6×FY 2022: 0.5×
FY 2018 5y median 0.4× FY 2022
Net Debt / EBITDA 0.6×
FY 2018: 3.3×FY 2019: -0.1×FY 2020: 3.1×FY 2021: 1.3×FY 2022: 0.6×
FY 2018 5y median 1.3× FY 2022
Interest Coverage -8.3×
FY 2018: -346×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -8.3×
FY 2018 5y median 0.0× FY 2022

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2018 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2018 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31